Skip to main content

Table 1 Baseline characteristics of subjects with metabolic syndrome

From: Effects of curcumin and/or coenzyme Q10 supplementation on metabolic control in subjects with metabolic syndrome: a randomized clinical trial

 

CP group (n = 22)

QP group (n = 22)

CQ group (n = 22)

DP group (n = 22)

P

Age, y

38.8 ± 4.9

39.0 ± 4.5

37.7 ± 5.0

39.5 ± 5.0

0.41

Sex, n (%)

    

0.19

 Male

14 (64)

13 (59)

13 (59)

15 (68)

 

 Female

8 (36)

9 (41)

9 (41)

7 (32)

 

Physical activity, MET-h/d

26.1 ± 2.6

27.8 ± 3.8

24.9 ± 4.1

28.1 ± 5.1

0.71

Energy intake, kcal/d

2285.7 ± 35

2275.3 ± 42

2290.1 ± 38

2210.8 ± 40

0.26

TG, mg/dL

224.7 ± 66.9

244.6 ± 95.2

236.8 ± 64.1

231.7 ± 80.7

0.58

HDL-c, mg/dL

32.0 ± 5.6

32.9 ± 4.7

31.2 ± 7.5

33.3 ± 8.5

0.41

SBP, mmHg

130.2 ± 7.5

127.2 ± 10.8

126.2 ± 10.4

135.1 ± 14.2

0.82

DBP, mmHg

91.0 ± 8.4

92.0 ± 7.9

93.1 ± 6.7

92.6 ± 6.5

0.84

WC, cm

101.0 ± 8.4

102.1 ± 6.5

102.7 ± 6.6

101.8 ± 7.7

0.13

FPG, mg/dL

130.1 ± 9.7

128.2 ± 14.3

121.2 ± 9.8

130.1 ± 14.7

0.27

  1. Data are expressed as mean ± standard deviation. CP curcumin plus placebo, QP coenzyme Q10 plus placebo, CQ curcumin plus coenzyme Q10, DP double placebo, MET-h metabolic equivalent task hours, TG triglyceride, HDL-c high density lipoprotein-cholesterol, SBP systolic blood pressure, DBP diastolic blood pressure, WC waist circumference, FPG fasting plasma glucose